Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 4, 2009

 

 

QuadraMed Corporation

(Exact name of registrant as specified in its charter)

 

 

 

Delaware		001-32283		52-1992861
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

12110 Sunset Hills Road, Suite 600, Reston, VA 20190

(Address of principal executive office and zip code)

(703) 709-2300

(Registrant’s telephone number, including area code)

(Not Applicable)

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

---

Table of Contents

TABLE OF CONTENTS

 

ITEM 8.01

OTHER EVENTS.

SIGNATURES

---

Table of Contents

ITEM 8.01

OTHER EVENTS.

Results of 2009 Annual Meeting of Shareholders

 

(a)	At 9:00 A.M. on June 4, 2009, QuadraMed held its 2009 Annual Meeting of Stockholders at its headquarters, located at 12110 Sunset Hills Road, Suite 600, Reston, VA 20190.

 

(b)	The issued and outstanding shares of stock of the Company entitled to vote at the Annual Meeting consisted of 8,296,219 shares of common stock. The stockholders of the Company voted on three matters at the Annual Meeting, all of which were approved as follows:

 

(1)

Election of directors;

 

NOMINEE		FOR		WITHHELD
Robert L. Pevenstein		6,262,135		1,271,641
Julian A.L. Allen		7,026,414		507,362
Lawrence P. English		4,970,980		2,562,796
William K. Jurika		6,913,063		620,713
Robert W. Miller		6,332,867		1,200,909
James E. Peebles		6,960,160		573,616

 

(2)

A proposal to approve and ratify the adoption of the QuadraMed Corporation 2009 Stock Compensation Plan;

 

FOR		AGAINST		ABSTAIN		BROKER NON-VOTE
5,552,418		422,655		31,779		1,526,924

 

(3)

A proposal to approve and ratify the adoption of the QuadraMed Corporation 2008 Employee Stock Purchase Plan;

 

FOR		AGAINST		ABSTAIN		BROKER NON-VOTE
5,737,090		240,915		28,847		1,526,924

 

(4)

A proposal to approve BDO Seidman, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2009.

 

FOR		AGAINST		ABSTAIN		BROKER NON-VOTE
6,888,126		34,228		611,422		0

---

Table of Contents

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: June 5, 2009